Flourish Medical CEO Presents at LSI Emerging MedTech Summit

Joanne Rupprecht, CEO of Flourish Medical, LLC, will present a novel women’s health medical device at this year’s LSI Emerging MedTech Summit, taking place March 21-23 in Dana Point, California.

Flouish, dedicated to meeting the needs of the women’s health market, is the designer and manufacturer of a single-use disposable device that helps women manage stress urinary incontinence (SUI). Affecting more than 15 million women in the United States alone, stress incontinence is a condition that can affect women in many stages of life, and is the most common form of urinary incontinence.

At the summit, which connects medtech leaders with investors, Rupprecht will detail the SUI market, the lack of existing solutions for the SUI problem, and how Flourish is positioned to leverage current opportunities.

“In Flourish Medical, we have in place what we need to commercialize the device: an experienced team, a detailed plan, tremendous intellectual property and a clear path to regulatory approval,” says Rupprecht. The company is seeking $1.5 million in its seed round of funding, and $5 million in Series A funding upon FDA 510(k) clearance.

“The Flourish device means a positive lifestyle change for millions of women,” says Rupprecht. Research shows that fewer than 25% of women with incontinence seek medical advice or help for their problem, she explains, and that many of them are not candidates for surgery. Others simply prefer not to have surgery or an invasive procedure. “Flourish provides the chance for these women to easily manage this condition and engage in all the activities they wish to, without worry.”

Flourish Medical, LLC (

Flourish Medical, LLC, is a medical device development and manufacturing company serving the needs of the women’s health market. The company’s flagship product, Flourish, is a novel, single-use, disposable device that helps women manage stress urinary incontinence. Flourish Medical is based in Boulder, Colorado.

Motif FoodWorks Partners with IngredientWerks on Research to Expand Technology Portfolio with Molecular Farming

Helika Closes $4M Seed Funding Round To Expand Analytics Product Offering For Web3